145 related articles for article (PubMed ID: 1290031)
1. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
[TBL] [Abstract][Full Text] [Related]
2. Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
Cunningham RT; Johnston CF; Irvine GB; Buchanan KD
Clin Chim Acta; 1992 Nov; 212(3):123-31. PubMed ID: 1477975
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
4. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
Simpson S; Vinik AI; Marangos PJ; Lloyd RV
Cancer; 1984 Oct; 54(7):1364-9. PubMed ID: 6088026
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Prinz RA; Marangos PJ
Am J Surg; 1983 Jan; 145(1):77-81. PubMed ID: 6295198
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Oishi S; Sato T
Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
[TBL] [Abstract][Full Text] [Related]
10. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
11. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
12. Clinical biochemistry of neuron specific enolase.
Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
[TBL] [Abstract][Full Text] [Related]
13. Biochemistry of neuroendocrine tumours.
de Herder WW
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
[TBL] [Abstract][Full Text] [Related]
14. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
Yaman O; Baltaci S; Arikan N; Ozdiler E; Göğüş O; Müftüoğlu YZ
Int Urol Nephrol; 1996; 28(2):207-10. PubMed ID: 8836790
[TBL] [Abstract][Full Text] [Related]
15. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
16. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
Grouzmann E; Gicquel C; Plouin PF; Schlumberger M; Comoy E; Bohuon C
Cancer; 1990 Oct; 66(8):1833-5. PubMed ID: 2208039
[TBL] [Abstract][Full Text] [Related]
18. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
19. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract][Full Text] [Related]
20. [The value of neuron specific enolase (NSE) in patients with brain tumors].
Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]